Jubilant Pharmova has informed that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2022 were approved by the Board of Directors of the Company at its meeting held today at 11:15 am and concluded at 12.45 pm. Pursuant to the applicable provisions of the Listing Regulations, it enclosed the following: The Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2022; Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter; and copies of the Press Release and Presentation.
The above information is a part of company’s filings submitted to BSE.
